Mutations and differential expression of the ras family genes in human nasal polyposis

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1051-1059

  Zaravinos, Apostolos ^a   Bizakis, John ^b   Soufla, Giannoula ^a   Sourvinos, George ^a   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Gene expression; Mutations; Nasal polyps; Ras genes; Real time RT PCR

Indexed keywords

MESSENGER RNA; PROTEIN P21;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CODON; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; NOSE POLYP; ONCOGENE RAS; PATHOLOGY;

ADULT; AGED; CODON; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; NASAL POLYPS; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, MESSENGER;

EID: 38449100394     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lund VJ: Diagnosis and treatment of nasal polyps. BMJ 311: 1411-1414, 1995.
2. Connell JT: Nasal hypersensitivity. In: Comprehensive Immunology. Gupta S and Good RA (eds.) Plenum Publ. Corp., New York, pp6, 1979.
3. Cauna N, Manzetti GW, Hinderer KH and Swanson EW: Fine structure of nasal polyps. Ann Otol Rhinol Laryngol 81: 41-58, 1972.
4. Kakoi H and Hiraide F: A histological study of formation and growth of nasal polyps. Acta Otolaryngol 103: 137-144, 1987.
5. Roche WR, Williams JH, Beasley R and Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524, 1989.
6. Pronk GJ and Bos JL: The role of p21 ras in receptor tyrosine kinase signalling. Biochem Biophys Acta 1198: 131-147, 1994.
7. Dokianakis DN, Sourvinos G, Sakkas S, et al: Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Oncol Rep 5: 1195-1198, 1998.
8. Koffa M, Malamou-Mitsi V, Agnantis NJ and Spandidos DA: Mutational activation of K-ras oncogene in human breast tumours. Int J Oncol 4: 573-576, 1994.
9. Roth S, Partanen T, Suitiala T, Anttila S, Ojajärvi A, Hemminki K, Vainio H and Husgafvel-Pursiainen K: Molecular analysis of occupational cancer: infrequent p53 and ras mutations in renal-cell cancer in workers exposed to gasoline. Int J Cancer 14: 492-496, 1997.
10. Kim TY, Bang YJ, Kim WS, et al: Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype. Anticancer Res 17: 1335-1340, 1997.
11. Mulder MP, Keijzer W, Boot AJM, et al: Activated ras genes in human seminomas: evidence for tumour heterogeneity. Oncogene 4: 1345-1351, 1989.
12. Hongyo T, Buzard GS, Palli D, et al: Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 55: 2665-2672, 1995.
13. Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037-1043, 1990.
14. Grimmond SM, Raghavan D and Russell PJ: Detection of rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing. Urol Res 20: 121-126, 1992.
15. Spandidos DA and Wilkie NM: Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310: 469-475, 1984.
16. Field JK and Spandidos DA: The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Res 10: 1-22, 1990.
17. Kiaris H, Spandidos DA, Jones AS, et al: Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br J Cancer 72: 123-129, 1995.
18. Spandidos DA, Sourvinos G, Tsatsanis C and Zafiropoulos A: Normal ras genes: Their onco-suppressor and pro-apoptotic functions (Review). Int J Oncol 21: 237-241, 2002.
19. Miyakis S, Sourvinos G and Spandidos DA: Differential expression and mutation of the ras family genes in human breast cancer. Biochem Biophys Res Commun 251: 609-612, 1998.
20. Malm L: Assessment and staging of nasal polyposis. Acta Otolaryngol 117: 465-467, 1997.
21. Kiaris H and Spandidos DA: Mutations of ras genes in human tumors. Int J Oncol 7: 413-421, 1995.
22. Tada M, Omata M, Kawai S, et al: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472-2474, 1993.
23. Spandidos DA, Glarakis IS, Kotsinas A, Ergazaki M and Kiaris H: Ras oncogene activation in benign and malignant colorectal tumours. Tumori 81: 7-11, 1995.
24. Spandidos DA, Liloglou T, Arvanitis D and Gourtsoyiannis NC: Ras gene activation in human small intestinal tumors. Int J Oncol 2: 513-518, 1993.
25. Tada M, Omata M and Ohto M: Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 50: 1121-1124, 1990.
26. Ignar-Trowbridge D, Risinger JI, Dent GA, et al: Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 167: 227-232, 1992.
27. Enomoto T, Inoue M, Perantoni AO, et al: K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res 51: 5308-5314, 1991.
28. Koffa M, Malamou-Mitsi V, Agnantis NJ and Spandidos DA: Mutational activation of the K-ras oncogene in human breast tumors. Int J Oncol 4: 573-576, 1994.
29. Rodenhuis S and Slebos RJ: Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52: S2665-S2669, 1992.
30. Rosell R, Li S, Skacel Z, et al: Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene 8: 2407-2412, 1993.
31. Glarakis IS, Savva S and Spandidos DA: Activation of the ras genes in malignant and premalignant colorectal tumors. Oncol Rep 5: 1451-1454, 1998.
32. Kinzel KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
33. Zachos G and Spandidos DA: Transcriptional regulation of the H-ras1 proto-oncogene. Gene Ther Mol Biol 1: 629-639, 1998.